Short Courses - The Molecular Medicine Tri Conference

2019 Archived Content

March 10-11, 2019 | Moscone South Convention Center

Cambridge Healthtech Institute is pleased to offer short courses taking place on Sunday and Monday at the Moscone South Convention Center. The short courses are designed to be instructional, interactive and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference programs that take place Monday-Wednesday or symposia and training seminars that take place Thursday-Friday.

SUNDAY, MARCH 10, 2:00 - 5:00 PM (AFTERNOON SHORT COURSES)

SC1: Precision Medicine 101: Genomic Literacy, Medical Applications, Risk and Regulation - Detailed Agenda

Jeanette McCarthy, MPH, PhD, Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

101/102

SC2: Coverage and Reimbursement for Advanced Diagnostics - Detailed Agenda

Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.

Becky Foster, Principal, Foster Health Care Consulting

John Warren, Senior Director, McDermott + Consulting

103

Co-Organized with

SC3: NGS Assay Selection, Validation and Compliance- Detailed Agenda

Birgit Funke, PhD, FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)

Karl Voelkerding, MD, Professor of Pathology, University of Utah School of Medicine (AMP Member)

Avni Santani, PhD, Director, Genomic Diagnostics, Children’s Hospital of Philadelphia (AMP Member)

154

SC4: Translating CTCs and ctDNA for Clinical Use - Detailed Agenda

Sonya Parpart-Li, PhD, Senior Research Scientist, Memorial Sloan Kettering Cancer Center

Gozde Durmus, PhD, Postdoctoral Research Fellow, Stanford Genome Technology Center, Department of Biochemistry, Stanford University School of Medicine

Prachi Kothari, DO, Instructor, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

151

SC6: Data Visualization - Detailed Agenda

Nils Gehlenborg, PhD, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

SC7: Omic Technology for Cancer Immunology - Detailed Agenda

Justina Caushi, Graduate Student, Johns Hopkins University

Joshua Eric Elias-Merriman, PhD, Assistant Professor, Chemical and Systems Biology, Stanford University

152

SC8: Data-Driven Process Development in the Clinical Laboratory - Detailed Agenda

Robert Young, CGMBS, MS Bioinformatics, Owner and Principal Consultant, Lab Insights, LLC

105

SUNDAY, MARCH 10, 5:30 - 8:30 PM (DINNER SHORT COURSES)

SC10: Regulatory Compliance in Molecular Diagnostics - Detailed Agenda

Melina Cimler, PhD, CEO & Founder, PandiaDx

Pamela Swatkowski, President, Regulatory Affairs & Compliance, PLS Consulting, LLC

Morteza Minaee, LPD, RAC, Vice President, Regulatory Affairs, Guardant Health, Inc.

152

SC11: Companion Diagnostics for Immuno-Oncology - Detailed Agenda

Kenneth Emancipator, MD, DABP, Executive Medical Director and Head of Companion Diagnostics, Merck & Co., Inc.

Mary J. Savage, Scientific Director, Companion Diagnostics, Merck & Co., Inc.

Deepti Aurora-Garg, Director, Companion Diagnostics, Merck & Co., Inc.

101/102

Co-Organized with

SC12: Clinical Informatics: Returning Results from Big Data - Detailed Agenda

Mark Routbort, MD, PhD, Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee; Member)

Somak Roy, MD, Director, Molecular Informatics, Genetics Services, & MGP Fellowship, Molecular and Genomic Pathology, University of Pittsburgh Medical Center (AMP Member)

103

SC13: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization - Detailed Agenda

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Evan F Cromwell, President & CEO, Protein Fluidics

Kris Buchanan, CEO and Founder, Phase Three Product Development

Viktor Shkolnikov, PhD, HP Labs, Microfluidics

Richard Spero, PhD, Co-founder, CEO, Redbud Labs

154

SC14: Liquid Biopsy Technologies and Applications - Detailed Agenda

John Simmons, PhD, Vice President, Translational Medicine, Personal Genome Diagnostics

Hatim Husain, MD, Physician, Medical Oncology, University of California, San Diego

151

SC15: Development of Bioassays for Checkpoint Immunotherapy - Detailed Agenda

Sofie Pattijn, CTO, ImmunXperts

105

SC16: Applications of Artificial Intelligence in Drug Discovery & Development - Detailed Agenda

Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan

Kuan-Fu Ding, MSc, PhD, Chief Science Officer, Sapiens Data Science

Orly Ardon, MSc, MBA, PhD, Program Manager, Research and Development, ARUP Laboratories/University of Utah

Hugo Geerts, PhD, BachMed, PharmaMBA, CSO, Computational Neuropharmacology, In Silico Biosciences Inc.

153

MONDAY, MARCH 11, 8:00 - 11:00 AM (MORNING SHORT COURSES)

SC17: Next-Generation Sequencing as a Diagnostics Platform - Detailed Agenda

Madhuri Hegde, PhD, FACMG, Professor, Human Genetics; Executive Director, Emory Genetics Laboratory, Emory University School of Medicine

Additional Instructors to be Announced

153

SC18: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics - Detailed Agenda

Harry Glorikian, MBA, Healthcare Consultant

Stan Skrzypczak, MBA, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

103

SC19: NGS for Infectious Disease Diagnostics - Detailed Agenda

Charles Chiu, MD, PhD, Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University of California, San Francisco

1 & 2

SC20: Digital Pathology: A-Z for Beginners - Detailed Agenda

Matthew G. Hanna, MD, Clinical Instructor, Breast and Informatics, Department of Pathology, Memorial Sloan Kettering Cancer Center

152

SC21: Detection and Characterization of Circulating Biomarkers - Detailed Agenda

Catherine Alix-Panabières, PhD, Director, Laboratory of Rare Human Circulating Cells (LCCRH), Pathology and Onco-Biology Department, University Medical Center of Montpellier, France

Klaus Pantel, MD, Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany

151

SC22: Cellular Phenotyping Assays in Oncology Trials - Detailed Agenda

Nathan Standifer, PhD, Senior Scientist, Clinical Pharmacology and DMPK, MedImmune

Mark Edinger, Scientific Affairs Director, Flow Cytometry, Q² Solutions

Linlin Xu, PhD, Scientist I, Clinical Pharmacology and DMPK, MedImmune

Megan McCausland, Senior Scientist, Translation Science Laboratory, Q² Solutions

101/102

SC23: Best Practices in Personalized and Translational Medicine - Detailed Agenda

Adam Brown, PhD, Technical Sales Manager, North America, SciBite
Susan Mockus, PhD, MBA, Associate Director, Clinical Genomic Market Development, The Jackson Laboratory for Genomic Medicine
Alex Sherman, Director, Center for Innovation and Bioinformatics, Neurological Clinical Research Institute, Massachusetts General Hospital; Principal Associate in Neurology, Harvard Medical School

Steve Penn, BSc, Strategy Lead, Medicinal Sciences Information, Pfizer

Jin Ruan, Director, Scientific Information Systems, Celgene

154

SC24: Connected Diagnostics: IoT, Sensors and Wearables Bring Point-of-Care Dx to the Patient - Detailed Agenda

Wasim Malik, PhD, Assistant Professor, Harvard Medical School

Valerie I. Photos, PhD, Managing Partner, Iaso Ventures

105